Skip to main content

The Roles of Contrast-Enhanced Harmonic Imaging in Treating Hepatocellular Carcinoma

  • Chapter
  • 83 Accesses

Abstract

As described in Chap. 4, ultrasonic blood flow imaging has five roles in the evaluation of hepatocellular carcinoma (HCC). They are (1) lesion detection or screening, (2) characterization (differential diagnosis), (3) evaluation of malignant grade, (4) staging, and (5) evaluation of treatment response. The last role is the most important because, although harmonic imaging contributes greatly to differential diagnosis of hepatic tumors, there are limitations on the ability to characterize tumors. HCC accounts for the largest number of hepatic tumors in Japan. Even if HCC is diagnosed by harmonic imaging, most cases also require further examination by computed tomography (CT) and angiography. Specifically, if most cases of hepatic tumors are HCC and borderline lesions accompanying HCC, then CT, magnetic resonance imaging (MRI), and angiography cannot be avoided to ensure more precise characterization and evaluation of malignant grade.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kudo M: Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. Hepato-Gastroenterology 1998; 45:1226–1231

    PubMed  Google Scholar 

  2. Kudo M: Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19:297–309

    Article  PubMed  CAS  Google Scholar 

  3. Ding H, Kudo M, Onda H, et al: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR 2001; 179:661–666

    Google Scholar 

  4. Ding H, Kudo M, Onda H, et al: Evaluation of posttreatment response for hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221:721–730

    Article  PubMed  CAS  Google Scholar 

  5. Kudo M: Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62(Suppl l):48–56

    Article  PubMed  Google Scholar 

  6. Minami Y, Kudo M, Kawasaki T: Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase- inversion harmonic sonography. AJR 2003; 180:703–708

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Japan

About this chapter

Cite this chapter

Kudo, M. (2003). The Roles of Contrast-Enhanced Harmonic Imaging in Treating Hepatocellular Carcinoma. In: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65904-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-65904-4_16

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-65906-8

  • Online ISBN: 978-4-431-65904-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics